Know Cancer

or
forgot password
  • cancer clinical trials in alabama

  • Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Northeast Alabama Regional Medical Center

    Trial Locations
    Northeast Alabama Regional Medical Center
    Providence Hospital
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    University of Alabama at Birmingham, Comprehensive Cancer Center
    Birmingham, Alabama
    Thyroid Cancer
    The Effect of TRA-8 on Ovarian Cancer Tissue
    University of Alabama
    Birmingham, Alabama
    Ovarian Cancer
    A Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer
    Quantum Immunologics
    Mobile, Alabama 36606
    Metastatic Breast Cancer
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
    1200.36.0016 Boehringer Ingelheim Investigational Site
    Birmingham, Alabama
    Glioma
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic Breast Cancer
    Anchorage Oncology Center

    Trial Locations
    Anchorage Oncology Center
    Northwest Healthcare: Kalispell Regional Medical Center
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Children's Hospital of Alabama

    Trial Locations
    Children's Hospital of Alabama
    University of South Alabama
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    MLN8237 in Young Patients With Relapsed or Refractory Solid Tumors or Acute Lymphoblastic Leukemia
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Leukemia, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
    DCH Cancer Treatment Center
    Tuscaloosa, Alabama 35401
    Breast Cancer, Carcinoma, Lumpectomy, Ductal Carcinoma in Situ
    Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer
    Southern Cancer Center

    Trial Locations
    Southern Cancer Center
    University Of South Alabama / Mitchell Cancer Institute
    Prostatic Neoplasms
    Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer
    Brachytherapy Site: Urology Centers of Alabama
    Birmingham, Alabama 35209
    Prostate Cancer
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
    Research Site
    Alabaster, Alabama
    Recurrent Glioblastoma
    A Study of Nilotinib Versus Imatinib in GIST Patients
    Birmingham Hematology and Oncology Associates
    Birmingham, Alabama 35235
    Gastrointestinal Stromal Tumor (GIST)
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Northeast Alabama Regional Medical Center

    Trial Locations
    Northeast Alabama Regional Medical Center
    Clearview Cancer Institute
    Cancer Center of Huntsville
    University of Southern Alabama
    Breast Cancer
    Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
    Children's Hospital of Alabama
    Birmingham, Alabama 35233
    Juvenile Idiopathic Arthritis
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    University of South Alabama Mitchell Cancer Institute
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    UAB Comprehensive Cancer Center

    Trial Locations
    UAB Comprehensive Cancer Center
    University of South Alabama Mitchell Cancer Institute
    Endometrial Cancer, Fatigue, Neurotoxicity
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Northeast Alabama Regional Medical Center

    Trial Locations
    Northeast Alabama Regional Medical Center
    Providence Hospital
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    UAB Comprenhensive Cancer Center at University of Alabama

    Trial Locations
    UAB Comprenhensive Cancer Center at University of Alabama
    Clearview Cancer Institute Oncology Specialities, P.C.
    Metastatic Pancreatic Cancer
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Oncology Specialties, PC
    Ovarian Cancer
    Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Small Cell Lung Cancer, Extensive Stage Lung Cancer, Chemonaive
    OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission
    University of South Alabama Mitchell Cancer Institute
    Mobile, Alabama 36604
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
    Research Site
    Alabaster, Alabama
    Non-Small Cell Lung Cancer, Anemia, Cancer, Lung Cancer
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    Southern Cancer Center
    Mobile, Alabama 36608
    Prostate Cancer
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    Regional Medical Center

    Trial Locations
    Regional Medical Center
    UAB Comprehensive Cancer Center
    Lung Cancer